MedTrace Logo

The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization

NCT02117843 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2017-06-27

No results posted yet for this study

Summary

The study is a Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization.

Conditions

  • Ischemic Heart Disease
  • Myocardial Ischemia
  • Coronary Disease
  • Acute Coronary Syndrome

Interventions

DEVICE

AVI® Arsenic trioxide drug eluting stent

AVI® Arsenic trioxide drug eluting stent

Sponsors & Collaborators

  • Beijing AmsinoMed Medical Device Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Yitong Ma, Prof. · First Affiliated Hospital of Xinjiang Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-12-31
Completion
2021-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02117843 on ClinicalTrials.gov